Innovation Centers / Center for Molecular & Behavioral Neuroscience

Center for Molecular & Behavioral Neuroscience

Center for Molecular & Behavioral Neuroscience Administration Team

Clivel Charlton, PhD

Director, Center for Molecular and Behavioral Neuroscience & Professor
School of Medicine
Center for Molecular & Behavioral Neuroscience

(615) 327-6971
ccharlton@mmc.edu

Center for Molecular & Behavioral Neuroscience Research Team

Clivel Charlton, PhD

Director, Center for Molecular and Behavioral Neuroscience & Professor
School of Medicine
Center for Molecular & Behavioral Neuroscience

(615) 327-6971
ccharlton@mmc.edu

Center for Molecular & Behavioral Neuroscience Team Publications

Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins.
Tewary P, Brooks AD, Xu YM, Wijeratne EMK, Babyak AL, Back TC, Chari R, Evans CN, Henrich CJ, Meyer TJ, Edmondson EF, Prudente de Aquino MT, Kanagasabai T, Shanker A, Gunatilaka AAL, Sayers TJ

Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1.
Renrick AN, Thounaojam MC, de Aquino MTP, Chaudhuri E, Pandhare J, Dash C, Shanker A

Activation of proline biosynthesis is critical to maintain glutamate homeostasis during acute methamphetamine exposure.
Jones B, Balasubramaniam M, Lebowitz JJ, Taylor A, Villalta F, Khoshbouei H, Grueter C, Grueter B, Dash C, Pandhare J

COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges.
Pathania AS, Prathipati P, Abdul BA, Chava S, Katta SS, Gupta SC, Gangula PR, Pandey MK, Durden DL, Byrareddy SN, Challagundla KB

Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508).
Patel JD, Lee JW, Carbone DP, Wagner H, Shanker A, de Aquino MTP, Horn L, Johnson ML, Gerber DE, Liu JJ, Das MS, Al-Nsour MA, Dakhil CSR, Ramalingam S, Schiller JH